Forward-Pharma GmbH
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis (NCT01815723) | Forward-Pharma GmbH | 2016-06-01 |
| Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis (NCT01230138) | Forward-Pharma GmbH | 2010-09-01 |
Track Forward-Pharma GmbH automatically
Every clearance here is in the API, with alerts when new ones post.